Tag: U.K.
-
Personalized Computer Models Developed for Heart Disease
Researchers in the U.K. are developing computer models of heart functions that enable physicians to simulate recommended treatments for individual patients to gauge and optimize their outcomes.
-
U.K. Pharmas, Regulators Agree on Faster Drug Review
Drug makers and regulators in the U.K. agreed on new review processes for more effective therapies in company pipelines, in exchange for caps on branded drug sales, which is expected to save £930 million ($US 1.2 billion) next year.
-
Faster Crop Breeding Techniques Made Available to Other Scientists
Plant scientists in the U.K. and Australia are making available to their colleagues experimental techniques that speed-up breeding cycles for more commercial crop varieties.
-
Rapid Antimicrobial Resistance Diagnostics System Advances
Developers of a system that uses high-speed genomic analysis with standard semiconductor chips say they demonstrated an ability to sequence bacterial DNA directly from raw blood samples.
-
Genome Editing, Informatics Lead to New Antibiotic
Researchers in the U.K. created an antibiotic acid from a natural microbe found in soil, using a combination of the genome editing technique Crispr and bioinformatics.
-
Model Biotech Materials Sharing Agreement Unveiled
A document with standard legal language for terms and conditions of sharing biotechnology materials is now available for academic and industry research labs.
-
Artificial Pancreas Controls Type 1 Diabetes Better Than Insulin Pump Alone
A clinical trial shows a closed-loop algorithm-controlled artificial pancreas system helps people with type 1 diabetes better control their blood sugar levels than a glucose sensor and insulin pump system alone.
-
Jet Fuel from Carbon Waste Powers Virgin Atlantic Flight
A Virgin Atlantic flight arriving earlier today from Orlando, Florida to London’s Gatwick airport is the first to use a biofuel made from fermented carbon-rich industrial waste gases.
-
Human Antibodies Devised for Snakebite Treatment
An academic-industry team in Europe and Central America assembled a group of human antibodies that protects lab mice against venomous toxins from a dangerous African snake.
-
Spin-Off Company Developing New Antibiotics
A start-up enterprise in the U.K. is commercializing research from a university lab that discovered a new class of antibiotics promising to treat drug-resistant bacterial infections.